KAM
Krensavage Asset Management’s NextCure NXTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-31,298
| Closed | -$86K | – | 14 |
|
|
2022
Q3 | $86K | Buy |
31,298
+299
| +1% | +$822 | 0.03% | 14 |
|
|
2022
Q2 | $146K | Buy |
30,999
+408
| +1% | +$1.92K | 0.05% | 13 |
|
|
2022
Q1 | $149K | Sell |
30,591
-436
| -1% | -$2.12K | 0.05% | 12 |
|
|
2021
Q4 | $186K | Buy |
31,027
+100
| +0.3% | +$599 | 0.06% | 10 |
|
|
2021
Q3 | $208K | Sell |
30,927
-428
| -1% | -$2.88K | 0.07% | 13 |
|
|
2021
Q2 | $252K | Buy |
31,355
+752
| +2% | +$6.04K | 0.09% | 13 |
|
|
2021
Q1 | $306K | Buy |
30,603
+311
| +1% | +$3.11K | 0.11% | 12 |
|
|
2020
Q4 | $330K | Buy |
+30,292
| New | +$330K | 0.1% | 12 |
|